Abbott Labs Stock Declines Despite Q1 Earnings Beat, Lowers Q2 Outlook

Abbott Laboratories' shares fell after reporting solid first-quarter results but disappointing second-quarter earnings guidance.

Abbott Laboratories exceeded first-quarter expectations with a profit of $1.23 billion and earnings of 98 cents per share.
Despite surpassing Q1 forecasts, Abbott's stock dropped due to lower than expected second-quarter earnings projections.
Medical devices segment showed strong growth with notable increases in electrophysiology and wearable glucose monitor sales.
The company raised the lower end of its full-year earnings forecast, now expecting $4.55 to $4.70 per share.
Abbott's diagnostics division continues to struggle post-pandemic, with sales down 17.6% compared to last year.